nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—ABCG2—lung cancer	0.226	0.706	CbGaD
Telmisartan—ABCB1—lung cancer	0.0942	0.294	CbGaD
Telmisartan—SLCO1B3—Paclitaxel—lung cancer	0.0337	0.07	CbGbCtD
Telmisartan—ABCG2—Topotecan—lung cancer	0.0315	0.0655	CbGbCtD
Telmisartan—ABCG2—Gefitinib—lung cancer	0.0288	0.0599	CbGbCtD
Telmisartan—ABCG2—Teniposide—lung cancer	0.0279	0.0581	CbGbCtD
Telmisartan—SLCO1B3—Docetaxel—lung cancer	0.0243	0.0506	CbGbCtD
Telmisartan—SLCO1B3—Methotrexate—lung cancer	0.0176	0.0366	CbGbCtD
Telmisartan—ABCC2—Paclitaxel—lung cancer	0.0172	0.0358	CbGbCtD
Telmisartan—ABCG2—Erlotinib—lung cancer	0.017	0.0354	CbGbCtD
Telmisartan—ABCC2—Irinotecan—lung cancer	0.017	0.0354	CbGbCtD
Telmisartan—ABCG2—Paclitaxel—lung cancer	0.0156	0.0324	CbGbCtD
Telmisartan—ABCG2—Irinotecan—lung cancer	0.0154	0.032	CbGbCtD
Telmisartan—ABCC2—Vinblastine—lung cancer	0.0151	0.0314	CbGbCtD
Telmisartan—ABCC2—Cisplatin—lung cancer	0.0139	0.0288	CbGbCtD
Telmisartan—ABCC2—Etoposide—lung cancer	0.0136	0.0283	CbGbCtD
Telmisartan—CYP2C19—Gefitinib—lung cancer	0.0129	0.0268	CbGbCtD
Telmisartan—ABCG2—Cisplatin—lung cancer	0.0125	0.0261	CbGbCtD
Telmisartan—CYP2C19—Teniposide—lung cancer	0.0125	0.0259	CbGbCtD
Telmisartan—ABCC2—Docetaxel—lung cancer	0.0125	0.0259	CbGbCtD
Telmisartan—ABCG2—Etoposide—lung cancer	0.0123	0.0256	CbGbCtD
Telmisartan—ABCB1—Topotecan—lung cancer	0.0113	0.0236	CbGbCtD
Telmisartan—ABCG2—Docetaxel—lung cancer	0.0113	0.0234	CbGbCtD
Telmisartan—ABCB1—Gefitinib—lung cancer	0.0104	0.0216	CbGbCtD
Telmisartan—ABCC2—Doxorubicin—lung cancer	0.00928	0.0193	CbGbCtD
Telmisartan—ABCC2—Methotrexate—lung cancer	0.00899	0.0187	CbGbCtD
Telmisartan—ABCG2—Doxorubicin—lung cancer	0.00839	0.0175	CbGbCtD
Telmisartan—ABCG2—Methotrexate—lung cancer	0.00813	0.0169	CbGbCtD
Telmisartan—ABCB1—Vinorelbine—lung cancer	0.00799	0.0166	CbGbCtD
Telmisartan—ABCB1—Crizotinib—lung cancer	0.00636	0.0132	CbGbCtD
Telmisartan—ABCB1—Gemcitabine—lung cancer	0.00622	0.0129	CbGbCtD
Telmisartan—ABCB1—Erlotinib—lung cancer	0.00613	0.0128	CbGbCtD
Telmisartan—ABCB1—Paclitaxel—lung cancer	0.00562	0.0117	CbGbCtD
Telmisartan—ABCB1—Irinotecan—lung cancer	0.00554	0.0115	CbGbCtD
Telmisartan—ABCB1—Vinblastine—lung cancer	0.00493	0.0102	CbGbCtD
Telmisartan—ABCB1—Cisplatin—lung cancer	0.00452	0.0094	CbGbCtD
Telmisartan—ABCB1—Etoposide—lung cancer	0.00444	0.00923	CbGbCtD
Telmisartan—ABCB1—Docetaxel—lung cancer	0.00406	0.00845	CbGbCtD
Telmisartan—ABCB1—Doxorubicin—lung cancer	0.00303	0.0063	CbGbCtD
Telmisartan—ABCB1—Methotrexate—lung cancer	0.00293	0.0061	CbGbCtD
Telmisartan—PPARG—Irinotecan—Topotecan—lung cancer	0.000978	0.33	CbGdCrCtD
Telmisartan—PPARG—Topotecan—Irinotecan—lung cancer	0.000813	0.274	CbGdCrCtD
Telmisartan—PPARG—Etoposide—Teniposide—lung cancer	0.000808	0.272	CbGdCrCtD
Telmisartan—Losartan—UGT1A1—lung cancer	0.000545	0.543	CrCbGaD
Telmisartan—PPARG—Teniposide—Etoposide—lung cancer	0.000366	0.124	CbGdCrCtD
Telmisartan—Candesartan—ABCB1—lung cancer	0.000198	0.197	CrCbGaD
Telmisartan—Losartan—ALB—lung cancer	0.000134	0.133	CrCbGaD
Telmisartan—Losartan—ABCB1—lung cancer	0.000127	0.127	CrCbGaD
Telmisartan—PPARG—mammary gland—lung cancer	9e-05	0.122	CbGeAlD
Telmisartan—SLCO1B3—lung—lung cancer	6.39e-05	0.0867	CbGeAlD
Telmisartan—AGTR1—epithelium—lung cancer	6.1e-05	0.0828	CbGeAlD
Telmisartan—PPARG—respiratory system—lung cancer	6e-05	0.0815	CbGeAlD
Telmisartan—AGTR1—trachea—lung cancer	5.39e-05	0.0732	CbGeAlD
Telmisartan—Fatigue—Etoposide—lung cancer	5.12e-05	0.000387	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	5.12e-05	0.000386	CcSEcCtD
Telmisartan—Constipation—Etoposide—lung cancer	5.08e-05	0.000384	CcSEcCtD
Telmisartan—Pain—Etoposide—lung cancer	5.08e-05	0.000384	CcSEcCtD
Telmisartan—Dysuria—Doxorubicin—lung cancer	5.07e-05	0.000383	CcSEcCtD
Telmisartan—AGTR1—cardiac atrium—lung cancer	5.06e-05	0.0688	CbGeAlD
Telmisartan—Decreased appetite—Paclitaxel—lung cancer	5.06e-05	0.000382	CcSEcCtD
Telmisartan—Dry mouth—Docetaxel—lung cancer	5.04e-05	0.00038	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Doxorubicin—lung cancer	5.04e-05	0.00038	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Paclitaxel—lung cancer	5.03e-05	0.00038	CcSEcCtD
Telmisartan—Fatigue—Paclitaxel—lung cancer	5.02e-05	0.000379	CcSEcCtD
Telmisartan—PPARG—epithelium—lung cancer	5.01e-05	0.0681	CbGeAlD
Telmisartan—Pollakiuria—Doxorubicin—lung cancer	5.01e-05	0.000378	CcSEcCtD
Telmisartan—Asthenia—Gemcitabine—lung cancer	4.99e-05	0.000377	CcSEcCtD
Telmisartan—Constipation—Paclitaxel—lung cancer	4.98e-05	0.000376	CcSEcCtD
Telmisartan—Pain—Paclitaxel—lung cancer	4.98e-05	0.000376	CcSEcCtD
Telmisartan—Pharyngitis—Methotrexate—lung cancer	4.97e-05	0.000375	CcSEcCtD
Telmisartan—Urinary tract disorder—Methotrexate—lung cancer	4.95e-05	0.000373	CcSEcCtD
Telmisartan—Anaphylactic shock—Docetaxel—lung cancer	4.94e-05	0.000373	CcSEcCtD
Telmisartan—Oedema—Docetaxel—lung cancer	4.94e-05	0.000373	CcSEcCtD
Telmisartan—Pruritus—Gemcitabine—lung cancer	4.92e-05	0.000372	CcSEcCtD
Telmisartan—Urethral disorder—Methotrexate—lung cancer	4.91e-05	0.000371	CcSEcCtD
Telmisartan—Infection—Docetaxel—lung cancer	4.91e-05	0.00037	CcSEcCtD
Telmisartan—Feeling abnormal—Etoposide—lung cancer	4.9e-05	0.00037	CcSEcCtD
Telmisartan—Diarrhoea—Irinotecan—lung cancer	4.89e-05	0.000369	CcSEcCtD
Telmisartan—Pneumonia—Doxorubicin—lung cancer	4.86e-05	0.000367	CcSEcCtD
Telmisartan—Gastrointestinal pain—Etoposide—lung cancer	4.86e-05	0.000367	CcSEcCtD
Telmisartan—Shock—Docetaxel—lung cancer	4.86e-05	0.000367	CcSEcCtD
Telmisartan—Nervous system disorder—Docetaxel—lung cancer	4.84e-05	0.000366	CcSEcCtD
Telmisartan—Thrombocytopenia—Docetaxel—lung cancer	4.83e-05	0.000365	CcSEcCtD
Telmisartan—Infestation—Doxorubicin—lung cancer	4.83e-05	0.000365	CcSEcCtD
Telmisartan—Infestation NOS—Doxorubicin—lung cancer	4.83e-05	0.000365	CcSEcCtD
Telmisartan—Visual impairment—Methotrexate—lung cancer	4.83e-05	0.000364	CcSEcCtD
Telmisartan—Tachycardia—Docetaxel—lung cancer	4.82e-05	0.000364	CcSEcCtD
Telmisartan—Feeling abnormal—Paclitaxel—lung cancer	4.8e-05	0.000362	CcSEcCtD
Telmisartan—Skin disorder—Docetaxel—lung cancer	4.8e-05	0.000362	CcSEcCtD
Telmisartan—Hypersensitivity—Cisplatin—lung cancer	4.78e-05	0.000361	CcSEcCtD
Telmisartan—Gastrointestinal pain—Paclitaxel—lung cancer	4.76e-05	0.00036	CcSEcCtD
Telmisartan—Diarrhoea—Gemcitabine—lung cancer	4.76e-05	0.000359	CcSEcCtD
Telmisartan—Renal failure—Doxorubicin—lung cancer	4.75e-05	0.000359	CcSEcCtD
Telmisartan—Neuropathy peripheral—Doxorubicin—lung cancer	4.74e-05	0.000358	CcSEcCtD
Telmisartan—Dizziness—Irinotecan—lung cancer	4.72e-05	0.000357	CcSEcCtD
Telmisartan—Urticaria—Etoposide—lung cancer	4.72e-05	0.000356	CcSEcCtD
Telmisartan—Anorexia—Docetaxel—lung cancer	4.71e-05	0.000355	CcSEcCtD
Telmisartan—Abdominal pain—Etoposide—lung cancer	4.7e-05	0.000355	CcSEcCtD
Telmisartan—Body temperature increased—Etoposide—lung cancer	4.7e-05	0.000355	CcSEcCtD
Telmisartan—Urinary tract infection—Doxorubicin—lung cancer	4.7e-05	0.000355	CcSEcCtD
Telmisartan—Conjunctivitis—Doxorubicin—lung cancer	4.7e-05	0.000355	CcSEcCtD
Telmisartan—Eye disorder—Methotrexate—lung cancer	4.68e-05	0.000353	CcSEcCtD
Telmisartan—Tinnitus—Methotrexate—lung cancer	4.67e-05	0.000353	CcSEcCtD
Telmisartan—Asthenia—Cisplatin—lung cancer	4.65e-05	0.000351	CcSEcCtD
Telmisartan—Cardiac disorder—Methotrexate—lung cancer	4.65e-05	0.000351	CcSEcCtD
Telmisartan—Urticaria—Paclitaxel—lung cancer	4.63e-05	0.000349	CcSEcCtD
Telmisartan—Hypotension—Docetaxel—lung cancer	4.61e-05	0.000348	CcSEcCtD
Telmisartan—Haematuria—Doxorubicin—lung cancer	4.61e-05	0.000348	CcSEcCtD
Telmisartan—Abdominal pain—Paclitaxel—lung cancer	4.61e-05	0.000348	CcSEcCtD
Telmisartan—Body temperature increased—Paclitaxel—lung cancer	4.61e-05	0.000348	CcSEcCtD
Telmisartan—Hepatobiliary disease—Doxorubicin—lung cancer	4.57e-05	0.000345	CcSEcCtD
Telmisartan—Epistaxis—Doxorubicin—lung cancer	4.56e-05	0.000344	CcSEcCtD
Telmisartan—Angiopathy—Methotrexate—lung cancer	4.54e-05	0.000343	CcSEcCtD
Telmisartan—Vomiting—Irinotecan—lung cancer	4.54e-05	0.000343	CcSEcCtD
Telmisartan—Sinusitis—Doxorubicin—lung cancer	4.53e-05	0.000342	CcSEcCtD
Telmisartan—Immune system disorder—Methotrexate—lung cancer	4.52e-05	0.000342	CcSEcCtD
Telmisartan—Mediastinal disorder—Methotrexate—lung cancer	4.51e-05	0.000341	CcSEcCtD
Telmisartan—Rash—Irinotecan—lung cancer	4.5e-05	0.00034	CcSEcCtD
Telmisartan—Dermatitis—Irinotecan—lung cancer	4.5e-05	0.00034	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Docetaxel—lung cancer	4.5e-05	0.00034	CcSEcCtD
Telmisartan—Chills—Methotrexate—lung cancer	4.49e-05	0.000339	CcSEcCtD
Telmisartan—Headache—Irinotecan—lung cancer	4.47e-05	0.000338	CcSEcCtD
Telmisartan—Insomnia—Docetaxel—lung cancer	4.47e-05	0.000337	CcSEcCtD
Telmisartan—Diarrhoea—Cisplatin—lung cancer	4.44e-05	0.000335	CcSEcCtD
Telmisartan—Paraesthesia—Docetaxel—lung cancer	4.43e-05	0.000335	CcSEcCtD
Telmisartan—Vomiting—Gemcitabine—lung cancer	4.42e-05	0.000334	CcSEcCtD
Telmisartan—Bradycardia—Doxorubicin—lung cancer	4.42e-05	0.000333	CcSEcCtD
Telmisartan—Dyspnoea—Docetaxel—lung cancer	4.4e-05	0.000332	CcSEcCtD
Telmisartan—Somnolence—Docetaxel—lung cancer	4.39e-05	0.000331	CcSEcCtD
Telmisartan—Mental disorder—Methotrexate—lung cancer	4.39e-05	0.000331	CcSEcCtD
Telmisartan—Rash—Gemcitabine—lung cancer	4.39e-05	0.000331	CcSEcCtD
Telmisartan—Dermatitis—Gemcitabine—lung cancer	4.38e-05	0.000331	CcSEcCtD
Telmisartan—Hypersensitivity—Etoposide—lung cancer	4.38e-05	0.000331	CcSEcCtD
Telmisartan—Erythema—Methotrexate—lung cancer	4.36e-05	0.000329	CcSEcCtD
Telmisartan—Malnutrition—Methotrexate—lung cancer	4.36e-05	0.000329	CcSEcCtD
Telmisartan—Headache—Gemcitabine—lung cancer	4.36e-05	0.000329	CcSEcCtD
Telmisartan—Rhinitis—Doxorubicin—lung cancer	4.35e-05	0.000328	CcSEcCtD
Telmisartan—Dyspepsia—Docetaxel—lung cancer	4.35e-05	0.000328	CcSEcCtD
Telmisartan—Hypoaesthesia—Doxorubicin—lung cancer	4.32e-05	0.000326	CcSEcCtD
Telmisartan—Pharyngitis—Doxorubicin—lung cancer	4.3e-05	0.000325	CcSEcCtD
Telmisartan—Decreased appetite—Docetaxel—lung cancer	4.29e-05	0.000324	CcSEcCtD
Telmisartan—Hypersensitivity—Paclitaxel—lung cancer	4.29e-05	0.000324	CcSEcCtD
Telmisartan—Urinary tract disorder—Doxorubicin—lung cancer	4.28e-05	0.000323	CcSEcCtD
Telmisartan—Oedema peripheral—Doxorubicin—lung cancer	4.27e-05	0.000323	CcSEcCtD
Telmisartan—Dysgeusia—Methotrexate—lung cancer	4.27e-05	0.000322	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Docetaxel—lung cancer	4.26e-05	0.000322	CcSEcCtD
Telmisartan—Asthenia—Etoposide—lung cancer	4.26e-05	0.000322	CcSEcCtD
Telmisartan—Connective tissue disorder—Doxorubicin—lung cancer	4.26e-05	0.000322	CcSEcCtD
Telmisartan—Fatigue—Docetaxel—lung cancer	4.26e-05	0.000321	CcSEcCtD
Telmisartan—Urethral disorder—Doxorubicin—lung cancer	4.25e-05	0.000321	CcSEcCtD
Telmisartan—Nausea—Irinotecan—lung cancer	4.24e-05	0.00032	CcSEcCtD
Telmisartan—Constipation—Docetaxel—lung cancer	4.22e-05	0.000319	CcSEcCtD
Telmisartan—Pain—Docetaxel—lung cancer	4.22e-05	0.000319	CcSEcCtD
Telmisartan—Back pain—Methotrexate—lung cancer	4.22e-05	0.000318	CcSEcCtD
Telmisartan—Pruritus—Etoposide—lung cancer	4.2e-05	0.000317	CcSEcCtD
Telmisartan—Visual impairment—Doxorubicin—lung cancer	4.18e-05	0.000316	CcSEcCtD
Telmisartan—Asthenia—Paclitaxel—lung cancer	4.18e-05	0.000316	CcSEcCtD
Telmisartan—Nausea—Gemcitabine—lung cancer	4.13e-05	0.000312	CcSEcCtD
Telmisartan—Vomiting—Cisplatin—lung cancer	4.12e-05	0.000311	CcSEcCtD
Telmisartan—Pruritus—Paclitaxel—lung cancer	4.12e-05	0.000311	CcSEcCtD
Telmisartan—Rash—Cisplatin—lung cancer	4.09e-05	0.000309	CcSEcCtD
Telmisartan—Dermatitis—Cisplatin—lung cancer	4.09e-05	0.000308	CcSEcCtD
Telmisartan—Feeling abnormal—Docetaxel—lung cancer	4.07e-05	0.000307	CcSEcCtD
Telmisartan—Diarrhoea—Etoposide—lung cancer	4.07e-05	0.000307	CcSEcCtD
Telmisartan—Eye disorder—Doxorubicin—lung cancer	4.05e-05	0.000306	CcSEcCtD
Telmisartan—Ill-defined disorder—Methotrexate—lung cancer	4.05e-05	0.000305	CcSEcCtD
Telmisartan—Tinnitus—Doxorubicin—lung cancer	4.04e-05	0.000305	CcSEcCtD
Telmisartan—Gastrointestinal pain—Docetaxel—lung cancer	4.04e-05	0.000305	CcSEcCtD
Telmisartan—Anaemia—Methotrexate—lung cancer	4.03e-05	0.000304	CcSEcCtD
Telmisartan—Cardiac disorder—Doxorubicin—lung cancer	4.03e-05	0.000304	CcSEcCtD
Telmisartan—Flushing—Doxorubicin—lung cancer	4.03e-05	0.000304	CcSEcCtD
Telmisartan—Diarrhoea—Paclitaxel—lung cancer	3.99e-05	0.000301	CcSEcCtD
Telmisartan—Angiopathy—Doxorubicin—lung cancer	3.94e-05	0.000297	CcSEcCtD
Telmisartan—Malaise—Methotrexate—lung cancer	3.93e-05	0.000297	CcSEcCtD
Telmisartan—Dizziness—Etoposide—lung cancer	3.93e-05	0.000297	CcSEcCtD
Telmisartan—Immune system disorder—Doxorubicin—lung cancer	3.92e-05	0.000296	CcSEcCtD
Telmisartan—Vertigo—Methotrexate—lung cancer	3.92e-05	0.000296	CcSEcCtD
Telmisartan—Mediastinal disorder—Doxorubicin—lung cancer	3.91e-05	0.000295	CcSEcCtD
Telmisartan—Abdominal pain—Docetaxel—lung cancer	3.9e-05	0.000295	CcSEcCtD
Telmisartan—Body temperature increased—Docetaxel—lung cancer	3.9e-05	0.000295	CcSEcCtD
Telmisartan—Chills—Doxorubicin—lung cancer	3.89e-05	0.000294	CcSEcCtD
Telmisartan—Arrhythmia—Doxorubicin—lung cancer	3.87e-05	0.000293	CcSEcCtD
Telmisartan—AGTR1—lung—lung cancer	3.87e-05	0.0526	CbGeAlD
Telmisartan—Dizziness—Paclitaxel—lung cancer	3.85e-05	0.000291	CcSEcCtD
Telmisartan—Nausea—Cisplatin—lung cancer	3.85e-05	0.000291	CcSEcCtD
Telmisartan—Cough—Methotrexate—lung cancer	3.81e-05	0.000287	CcSEcCtD
Telmisartan—Mental disorder—Doxorubicin—lung cancer	3.8e-05	0.000287	CcSEcCtD
Telmisartan—Vomiting—Etoposide—lung cancer	3.78e-05	0.000285	CcSEcCtD
Telmisartan—Erythema—Doxorubicin—lung cancer	3.78e-05	0.000285	CcSEcCtD
Telmisartan—Malnutrition—Doxorubicin—lung cancer	3.78e-05	0.000285	CcSEcCtD
Telmisartan—Rash—Etoposide—lung cancer	3.75e-05	0.000283	CcSEcCtD
Telmisartan—Dermatitis—Etoposide—lung cancer	3.74e-05	0.000283	CcSEcCtD
Telmisartan—Headache—Etoposide—lung cancer	3.72e-05	0.000281	CcSEcCtD
Telmisartan—Flatulence—Doxorubicin—lung cancer	3.72e-05	0.000281	CcSEcCtD
Telmisartan—Chest pain—Methotrexate—lung cancer	3.71e-05	0.00028	CcSEcCtD
Telmisartan—Arthralgia—Methotrexate—lung cancer	3.71e-05	0.00028	CcSEcCtD
Telmisartan—Myalgia—Methotrexate—lung cancer	3.71e-05	0.00028	CcSEcCtD
Telmisartan—Tension—Doxorubicin—lung cancer	3.71e-05	0.00028	CcSEcCtD
Telmisartan—Vomiting—Paclitaxel—lung cancer	3.7e-05	0.00028	CcSEcCtD
Telmisartan—Dysgeusia—Doxorubicin—lung cancer	3.7e-05	0.000279	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	3.69e-05	0.000278	CcSEcCtD
Telmisartan—Rash—Paclitaxel—lung cancer	3.67e-05	0.000277	CcSEcCtD
Telmisartan—Dermatitis—Paclitaxel—lung cancer	3.67e-05	0.000277	CcSEcCtD
Telmisartan—Discomfort—Methotrexate—lung cancer	3.67e-05	0.000277	CcSEcCtD
Telmisartan—Nervousness—Doxorubicin—lung cancer	3.67e-05	0.000277	CcSEcCtD
Telmisartan—Back pain—Doxorubicin—lung cancer	3.65e-05	0.000276	CcSEcCtD
Telmisartan—Headache—Paclitaxel—lung cancer	3.65e-05	0.000276	CcSEcCtD
Telmisartan—Hypersensitivity—Docetaxel—lung cancer	3.64e-05	0.000275	CcSEcCtD
Telmisartan—Muscle spasms—Doxorubicin—lung cancer	3.63e-05	0.000274	CcSEcCtD
Telmisartan—Anaphylactic shock—Methotrexate—lung cancer	3.56e-05	0.000269	CcSEcCtD
Telmisartan—Asthenia—Docetaxel—lung cancer	3.54e-05	0.000267	CcSEcCtD
Telmisartan—Infection—Methotrexate—lung cancer	3.54e-05	0.000267	CcSEcCtD
Telmisartan—Nausea—Etoposide—lung cancer	3.53e-05	0.000266	CcSEcCtD
Telmisartan—PPARG—bone marrow—lung cancer	3.52e-05	0.0477	CbGeAlD
Telmisartan—Ill-defined disorder—Doxorubicin—lung cancer	3.5e-05	0.000265	CcSEcCtD
Telmisartan—Pruritus—Docetaxel—lung cancer	3.49e-05	0.000264	CcSEcCtD
Telmisartan—Nervous system disorder—Methotrexate—lung cancer	3.49e-05	0.000264	CcSEcCtD
Telmisartan—Anaemia—Doxorubicin—lung cancer	3.49e-05	0.000263	CcSEcCtD
Telmisartan—Thrombocytopenia—Methotrexate—lung cancer	3.48e-05	0.000263	CcSEcCtD
Telmisartan—Nausea—Paclitaxel—lung cancer	3.46e-05	0.000261	CcSEcCtD
Telmisartan—Skin disorder—Methotrexate—lung cancer	3.46e-05	0.000261	CcSEcCtD
Telmisartan—Hyperhidrosis—Methotrexate—lung cancer	3.44e-05	0.00026	CcSEcCtD
Telmisartan—Malaise—Doxorubicin—lung cancer	3.4e-05	0.000257	CcSEcCtD
Telmisartan—Vertigo—Doxorubicin—lung cancer	3.39e-05	0.000256	CcSEcCtD
Telmisartan—Anorexia—Methotrexate—lung cancer	3.39e-05	0.000256	CcSEcCtD
Telmisartan—Syncope—Doxorubicin—lung cancer	3.39e-05	0.000256	CcSEcCtD
Telmisartan—Diarrhoea—Docetaxel—lung cancer	3.38e-05	0.000255	CcSEcCtD
Telmisartan—Palpitations—Doxorubicin—lung cancer	3.34e-05	0.000252	CcSEcCtD
Telmisartan—Hypotension—Methotrexate—lung cancer	3.33e-05	0.000251	CcSEcCtD
Telmisartan—Loss of consciousness—Doxorubicin—lung cancer	3.32e-05	0.000251	CcSEcCtD
Telmisartan—Cough—Doxorubicin—lung cancer	3.29e-05	0.000249	CcSEcCtD
Telmisartan—Dizziness—Docetaxel—lung cancer	3.27e-05	0.000247	CcSEcCtD
Telmisartan—Hypertension—Doxorubicin—lung cancer	3.26e-05	0.000246	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Methotrexate—lung cancer	3.24e-05	0.000245	CcSEcCtD
Telmisartan—Insomnia—Methotrexate—lung cancer	3.22e-05	0.000243	CcSEcCtD
Telmisartan—Myalgia—Doxorubicin—lung cancer	3.21e-05	0.000243	CcSEcCtD
Telmisartan—Chest pain—Doxorubicin—lung cancer	3.21e-05	0.000243	CcSEcCtD
Telmisartan—Arthralgia—Doxorubicin—lung cancer	3.21e-05	0.000243	CcSEcCtD
Telmisartan—Anxiety—Doxorubicin—lung cancer	3.2e-05	0.000242	CcSEcCtD
Telmisartan—Paraesthesia—Methotrexate—lung cancer	3.2e-05	0.000241	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	3.19e-05	0.000241	CcSEcCtD
Telmisartan—PPARG—lung—lung cancer	3.19e-05	0.0433	CbGeAlD
Telmisartan—Discomfort—Doxorubicin—lung cancer	3.18e-05	0.00024	CcSEcCtD
Telmisartan—Dyspnoea—Methotrexate—lung cancer	3.17e-05	0.00024	CcSEcCtD
Telmisartan—Somnolence—Methotrexate—lung cancer	3.16e-05	0.000239	CcSEcCtD
Telmisartan—Dry mouth—Doxorubicin—lung cancer	3.14e-05	0.000237	CcSEcCtD
Telmisartan—Vomiting—Docetaxel—lung cancer	3.14e-05	0.000237	CcSEcCtD
Telmisartan—Dyspepsia—Methotrexate—lung cancer	3.13e-05	0.000237	CcSEcCtD
Telmisartan—Rash—Docetaxel—lung cancer	3.11e-05	0.000235	CcSEcCtD
Telmisartan—Dermatitis—Docetaxel—lung cancer	3.11e-05	0.000235	CcSEcCtD
Telmisartan—Decreased appetite—Methotrexate—lung cancer	3.09e-05	0.000234	CcSEcCtD
Telmisartan—Headache—Docetaxel—lung cancer	3.09e-05	0.000234	CcSEcCtD
Telmisartan—Oedema—Doxorubicin—lung cancer	3.08e-05	0.000233	CcSEcCtD
Telmisartan—Anaphylactic shock—Doxorubicin—lung cancer	3.08e-05	0.000233	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Methotrexate—lung cancer	3.07e-05	0.000232	CcSEcCtD
Telmisartan—Fatigue—Methotrexate—lung cancer	3.07e-05	0.000232	CcSEcCtD
Telmisartan—Infection—Doxorubicin—lung cancer	3.06e-05	0.000231	CcSEcCtD
Telmisartan—Pain—Methotrexate—lung cancer	3.04e-05	0.00023	CcSEcCtD
Telmisartan—Shock—Doxorubicin—lung cancer	3.03e-05	0.000229	CcSEcCtD
Telmisartan—Nervous system disorder—Doxorubicin—lung cancer	3.02e-05	0.000228	CcSEcCtD
Telmisartan—Thrombocytopenia—Doxorubicin—lung cancer	3.02e-05	0.000228	CcSEcCtD
Telmisartan—Tachycardia—Doxorubicin—lung cancer	3.01e-05	0.000227	CcSEcCtD
Telmisartan—Skin disorder—Doxorubicin—lung cancer	2.99e-05	0.000226	CcSEcCtD
Telmisartan—Hyperhidrosis—Doxorubicin—lung cancer	2.98e-05	0.000225	CcSEcCtD
Telmisartan—Anorexia—Doxorubicin—lung cancer	2.94e-05	0.000222	CcSEcCtD
Telmisartan—Nausea—Docetaxel—lung cancer	2.93e-05	0.000221	CcSEcCtD
Telmisartan—Feeling abnormal—Methotrexate—lung cancer	2.93e-05	0.000221	CcSEcCtD
Telmisartan—Gastrointestinal pain—Methotrexate—lung cancer	2.91e-05	0.00022	CcSEcCtD
Telmisartan—Hypotension—Doxorubicin—lung cancer	2.88e-05	0.000217	CcSEcCtD
Telmisartan—Urticaria—Methotrexate—lung cancer	2.83e-05	0.000213	CcSEcCtD
Telmisartan—Body temperature increased—Methotrexate—lung cancer	2.81e-05	0.000212	CcSEcCtD
Telmisartan—Abdominal pain—Methotrexate—lung cancer	2.81e-05	0.000212	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.81e-05	0.000212	CcSEcCtD
Telmisartan—Insomnia—Doxorubicin—lung cancer	2.79e-05	0.00021	CcSEcCtD
Telmisartan—Paraesthesia—Doxorubicin—lung cancer	2.77e-05	0.000209	CcSEcCtD
Telmisartan—Dyspnoea—Doxorubicin—lung cancer	2.75e-05	0.000207	CcSEcCtD
Telmisartan—Somnolence—Doxorubicin—lung cancer	2.74e-05	0.000207	CcSEcCtD
Telmisartan—Dyspepsia—Doxorubicin—lung cancer	2.71e-05	0.000205	CcSEcCtD
Telmisartan—Decreased appetite—Doxorubicin—lung cancer	2.68e-05	0.000202	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Doxorubicin—lung cancer	2.66e-05	0.000201	CcSEcCtD
Telmisartan—Fatigue—Doxorubicin—lung cancer	2.66e-05	0.000201	CcSEcCtD
Telmisartan—AGTR1—lymph node—lung cancer	2.65e-05	0.036	CbGeAlD
Telmisartan—Pain—Doxorubicin—lung cancer	2.64e-05	0.000199	CcSEcCtD
Telmisartan—Constipation—Doxorubicin—lung cancer	2.64e-05	0.000199	CcSEcCtD
Telmisartan—Hypersensitivity—Methotrexate—lung cancer	2.62e-05	0.000198	CcSEcCtD
Telmisartan—Asthenia—Methotrexate—lung cancer	2.55e-05	0.000193	CcSEcCtD
Telmisartan—Feeling abnormal—Doxorubicin—lung cancer	2.54e-05	0.000192	CcSEcCtD
Telmisartan—Gastrointestinal pain—Doxorubicin—lung cancer	2.52e-05	0.00019	CcSEcCtD
Telmisartan—Pruritus—Methotrexate—lung cancer	2.52e-05	0.00019	CcSEcCtD
Telmisartan—Urticaria—Doxorubicin—lung cancer	2.45e-05	0.000185	CcSEcCtD
Telmisartan—Abdominal pain—Doxorubicin—lung cancer	2.44e-05	0.000184	CcSEcCtD
Telmisartan—Body temperature increased—Doxorubicin—lung cancer	2.44e-05	0.000184	CcSEcCtD
Telmisartan—Diarrhoea—Methotrexate—lung cancer	2.43e-05	0.000184	CcSEcCtD
Telmisartan—Dizziness—Methotrexate—lung cancer	2.35e-05	0.000178	CcSEcCtD
Telmisartan—Hypersensitivity—Doxorubicin—lung cancer	2.27e-05	0.000171	CcSEcCtD
Telmisartan—Vomiting—Methotrexate—lung cancer	2.26e-05	0.000171	CcSEcCtD
Telmisartan—ABCG2—bone marrow—lung cancer	2.25e-05	0.0306	CbGeAlD
Telmisartan—Rash—Methotrexate—lung cancer	2.24e-05	0.000169	CcSEcCtD
Telmisartan—Dermatitis—Methotrexate—lung cancer	2.24e-05	0.000169	CcSEcCtD
Telmisartan—Headache—Methotrexate—lung cancer	2.23e-05	0.000168	CcSEcCtD
Telmisartan—Asthenia—Doxorubicin—lung cancer	2.21e-05	0.000167	CcSEcCtD
Telmisartan—Pruritus—Doxorubicin—lung cancer	2.18e-05	0.000165	CcSEcCtD
Telmisartan—PPARG—lymph node—lung cancer	2.18e-05	0.0296	CbGeAlD
Telmisartan—Nausea—Methotrexate—lung cancer	2.11e-05	0.00016	CcSEcCtD
Telmisartan—Diarrhoea—Doxorubicin—lung cancer	2.11e-05	0.000159	CcSEcCtD
Telmisartan—ABCG2—lung—lung cancer	2.04e-05	0.0277	CbGeAlD
Telmisartan—Dizziness—Doxorubicin—lung cancer	2.04e-05	0.000154	CcSEcCtD
Telmisartan—Vomiting—Doxorubicin—lung cancer	1.96e-05	0.000148	CcSEcCtD
Telmisartan—Rash—Doxorubicin—lung cancer	1.94e-05	0.000147	CcSEcCtD
Telmisartan—Dermatitis—Doxorubicin—lung cancer	1.94e-05	0.000147	CcSEcCtD
Telmisartan—Headache—Doxorubicin—lung cancer	1.93e-05	0.000146	CcSEcCtD
Telmisartan—ABCC2—lymph node—lung cancer	1.91e-05	0.026	CbGeAlD
Telmisartan—ABCB1—respiratory system—lung cancer	1.9e-05	0.0257	CbGeAlD
Telmisartan—Nausea—Doxorubicin—lung cancer	1.83e-05	0.000138	CcSEcCtD
Telmisartan—ABCB1—epithelium—lung cancer	1.58e-05	0.0215	CbGeAlD
Telmisartan—ABCB1—trachea—lung cancer	1.4e-05	0.019	CbGeAlD
Telmisartan—ABCG2—lymph node—lung cancer	1.4e-05	0.019	CbGeAlD
Telmisartan—SLCO1B3—Metabolism—ERCC2—lung cancer	1.16e-05	0.000188	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL2—lung cancer	1.15e-05	0.000187	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—MYC—lung cancer	1.15e-05	0.000186	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTP1—lung cancer	1.15e-05	0.000186	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CB—lung cancer	1.14e-05	0.000185	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	1.14e-05	0.000184	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP2A7—lung cancer	1.14e-05	0.000184	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	1.13e-05	0.000184	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ENO1—lung cancer	1.13e-05	0.000183	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—CREBBP—lung cancer	1.13e-05	0.000183	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CAT—lung cancer	1.12e-05	0.000181	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MAPK3—lung cancer	1.11e-05	0.00018	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SDC4—lung cancer	1.11e-05	0.00018	CbGpPWpGaD
Telmisartan—ABCB1—bone marrow—lung cancer	1.11e-05	0.0151	CbGeAlD
Telmisartan—ABCB1—Metabolism—CYP2A7—lung cancer	1.11e-05	0.00018	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.11e-05	0.00018	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	1.1e-05	0.000178	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—RAF1—lung cancer	1.1e-05	0.000178	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	1.1e-05	0.000178	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCL8—lung cancer	1.09e-05	0.000177	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ERBB3—lung cancer	1.09e-05	0.000176	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SDC4—lung cancer	1.09e-05	0.000176	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ABCB1—lung cancer	1.08e-05	0.000176	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—TYMS—lung cancer	1.07e-05	0.000173	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EGFR—lung cancer	1.06e-05	0.000171	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ALB—lung cancer	1.06e-05	0.000171	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTM1—lung cancer	1.05e-05	0.000171	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.05e-05	0.00017	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL2—lung cancer	1.05e-05	0.00017	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TERT—lung cancer	1.04e-05	0.000169	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.02e-05	0.000165	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP2E1—lung cancer	1.01e-05	0.000164	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—RRM1—lung cancer	1.01e-05	0.000164	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTA3—lung cancer	1.01e-05	0.000164	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FGFR1—lung cancer	1.01e-05	0.000164	CbGpPWpGaD
Telmisartan—ABCB1—lung—lung cancer	1.01e-05	0.0137	CbGeAlD
Telmisartan—SLCO1B3—Metabolism—APOA1—lung cancer	1e-05	0.000163	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NQO1—lung cancer	1e-05	0.000162	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—KRAS—lung cancer	1e-05	0.000162	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP1A1—lung cancer	9.98e-06	0.000162	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HIF1A—lung cancer	9.97e-06	0.000162	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	9.91e-06	0.000161	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ERCC2—lung cancer	9.9e-06	0.00016	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—RRM1—lung cancer	9.89e-06	0.00016	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTA3—lung cancer	9.89e-06	0.00016	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APOA1—lung cancer	9.62e-06	0.000156	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.61e-06	0.000156	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—RAF1—lung cancer	9.56e-06	0.000155	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KDR—lung cancer	9.54e-06	0.000155	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—B4GALT5—lung cancer	9.52e-06	0.000154	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	9.43e-06	0.000153	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	9.38e-06	0.000152	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—CREBBP—lung cancer	9.33e-06	0.000151	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—B4GALT5—lung cancer	9.3e-06	0.000151	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTA4—lung cancer	9.26e-06	0.00015	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CG—lung cancer	9.17e-06	0.000149	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	9.12e-06	0.000148	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	9.05e-06	0.000147	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTA4—lung cancer	9.04e-06	0.000147	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—STK11—lung cancer	9.03e-06	0.000146	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTA2—lung cancer	9.03e-06	0.000146	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	8.92e-06	0.000145	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTA2—lung cancer	8.81e-06	0.000143	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KIT—lung cancer	8.78e-06	0.000142	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APC—lung cancer	8.78e-06	0.000142	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CG—lung cancer	8.78e-06	0.000142	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—NRAS—lung cancer	8.78e-06	0.000142	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—POMC—lung cancer	8.72e-06	0.000141	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTA1—lung cancer	8.71e-06	0.000141	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGF—lung cancer	8.68e-06	0.000141	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCC3—lung cancer	8.61e-06	0.00014	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—APOA1—lung cancer	8.57e-06	0.000139	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTA1—lung cancer	8.5e-06	0.000138	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CREBBP—lung cancer	8.5e-06	0.000138	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—HRAS—lung cancer	8.5e-06	0.000138	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	8.43e-06	0.000137	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—MAPK3—lung cancer	8.41e-06	0.000136	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ABCC3—lung cancer	8.41e-06	0.000136	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—POMC—lung cancer	8.36e-06	0.000135	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTP1—lung cancer	8.36e-06	0.000135	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKR1C1—lung cancer	8.34e-06	0.000135	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—BRAF—lung cancer	8.26e-06	0.000134	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.2e-06	0.000133	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6R—lung cancer	8.16e-06	0.000132	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CREBBP—lung cancer	8.14e-06	0.000132	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKR1C1—lung cancer	8.14e-06	0.000132	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6—lung cancer	8.13e-06	0.000132	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CAT—lung cancer	8.13e-06	0.000132	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—UGT1A1—lung cancer	8.1e-06	0.000131	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CD—lung cancer	8.06e-06	0.000131	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EGFR—lung cancer	8e-06	0.00013	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ALB—lung cancer	7.95e-06	0.000129	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ABCB1—lung cancer	7.91e-06	0.000128	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—UGT1A1—lung cancer	7.9e-06	0.000128	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CG—lung cancer	7.82e-06	0.000127	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GNG11—lung cancer	7.81e-06	0.000127	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAP2K1—lung cancer	7.77e-06	0.000126	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TYMS—lung cancer	7.77e-06	0.000126	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	7.77e-06	0.000126	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	7.74e-06	0.000125	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CD—lung cancer	7.72e-06	0.000125	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTM1—lung cancer	7.68e-06	0.000124	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CA—lung cancer	7.65e-06	0.000124	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GNG11—lung cancer	7.62e-06	0.000124	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—KRAS—lung cancer	7.56e-06	0.000123	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT1—lung cancer	7.5e-06	0.000122	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	7.49e-06	0.000121	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—POMC—lung cancer	7.44e-06	0.000121	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALDOA—lung cancer	7.43e-06	0.00012	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP1A1—lung cancer	7.28e-06	0.000118	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALDOA—lung cancer	7.26e-06	0.000118	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CREBBP—lung cancer	7.25e-06	0.000117	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ERCC2—lung cancer	7.22e-06	0.000117	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NCOA3—lung cancer	7.22e-06	0.000117	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	7.21e-06	0.000117	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	7.09e-06	0.000115	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NCOA3—lung cancer	7.04e-06	0.000114	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CB—lung cancer	7.02e-06	0.000114	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ADCY1—lung cancer	7.02e-06	0.000114	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCG2—lung cancer	7.02e-06	0.000114	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—lung cancer	6.96e-06	0.000113	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CA—lung cancer	6.95e-06	0.000113	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MDM2—lung cancer	6.92e-06	0.000112	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RAF1—lung cancer	6.89e-06	0.000112	CbGpPWpGaD
Telmisartan—ABCB1—lymph node—lung cancer	6.89e-06	0.00935	CbGeAlD
Telmisartan—CYP2C19—Metabolism—HPGDS—lung cancer	6.89e-06	0.000112	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ENO2—lung cancer	6.89e-06	0.000112	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CD—lung cancer	6.88e-06	0.000111	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ABCG2—lung cancer	6.85e-06	0.000111	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ADCY1—lung cancer	6.85e-06	0.000111	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPP2R1B—lung cancer	6.84e-06	0.000111	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ERBB2—lung cancer	6.82e-06	0.000111	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALB—lung cancer	6.79e-06	0.00011	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.75e-06	0.000109	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CB—lung cancer	6.73e-06	0.000109	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MTOR—lung cancer	6.73e-06	0.000109	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HPGDS—lung cancer	6.72e-06	0.000109	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ENO2—lung cancer	6.72e-06	0.000109	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTT1—lung cancer	6.68e-06	0.000108	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPP2R1B—lung cancer	6.68e-06	0.000108	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GCLC—lung cancer	6.6e-06	0.000107	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP2A6—lung cancer	6.6e-06	0.000107	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.58e-06	0.000107	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTT1—lung cancer	6.52e-06	0.000106	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL8—lung cancer	6.47e-06	0.000105	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GCLC—lung cancer	6.44e-06	0.000104	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP2A6—lung cancer	6.44e-06	0.000104	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—HRAS—lung cancer	6.43e-06	0.000104	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	6.33e-06	0.000103	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ENO1—lung cancer	6.26e-06	0.000101	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT1—lung cancer	6.25e-06	0.000101	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—APOA1—lung cancer	6.25e-06	0.000101	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.24e-06	0.000101	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CASP3—lung cancer	6.19e-06	0.0001	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2—lung cancer	6.18e-06	0.0001	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.16e-06	9.97e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6—lung cancer	6.15e-06	9.97e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ENO1—lung cancer	6.11e-06	9.9e-05	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	6.1e-06	9.89e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTEN—lung cancer	6.07e-06	9.83e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCND1—lung cancer	6.03e-06	9.76e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JUN—lung cancer	6.01e-06	9.74e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CB—lung cancer	5.99e-06	9.71e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—lung cancer	5.94e-06	9.62e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP9—lung cancer	5.85e-06	9.48e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1A—lung cancer	5.83e-06	9.45e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTEN—lung cancer	5.82e-06	9.42e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—EP300—lung cancer	5.79e-06	9.38e-05	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	5.71e-06	9.26e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CG—lung cancer	5.7e-06	9.24e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MAPK3—lung cancer	5.69e-06	9.22e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT1—lung cancer	5.67e-06	9.19e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP2E1—lung cancer	5.61e-06	9.1e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NQO1—lung cancer	5.55e-06	8.99e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EP300—lung cancer	5.55e-06	8.99e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MYC—lung cancer	5.53e-06	8.97e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP2E1—lung cancer	5.48e-06	8.88e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.43e-06	8.81e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—POMC—lung cancer	5.43e-06	8.8e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NQO1—lung cancer	5.42e-06	8.78e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SRC—lung cancer	5.39e-06	8.74e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.38e-06	8.73e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CREBBP—lung cancer	5.29e-06	8.57e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—lung cancer	5.25e-06	8.51e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—STAT3—lung cancer	5.2e-06	8.43e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NRAS—lung cancer	5.19e-06	8.41e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTEN—lung cancer	5.18e-06	8.39e-05	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	5.17e-06	8.37e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CD—lung cancer	5.01e-06	8.12e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—STK11—lung cancer	5e-06	8.11e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAPK3—lung cancer	4.97e-06	8.05e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALB—lung cancer	4.95e-06	8.02e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—EP300—lung cancer	4.94e-06	8e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—STK11—lung cancer	4.88e-06	7.91e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MYC—lung cancer	4.83e-06	7.83e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGFR—lung cancer	4.73e-06	7.66e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.7e-06	7.61e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTP1—lung cancer	4.63e-06	7.5e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTP1—lung cancer	4.52e-06	7.32e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CAT—lung cancer	4.5e-06	7.3e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.48e-06	7.26e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KRAS—lung cancer	4.47e-06	7.24e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CAT—lung cancer	4.4e-06	7.12e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCB1—lung cancer	4.38e-06	7.1e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CB—lung cancer	4.37e-06	7.08e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—lung cancer	4.33e-06	7.02e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TYMS—lung cancer	4.3e-06	6.97e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CA—lung cancer	4.28e-06	6.94e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTM1—lung cancer	4.25e-06	6.89e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TYMS—lung cancer	4.2e-06	6.81e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTM1—lung cancer	4.15e-06	6.73e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CA—lung cancer	4.1e-06	6.65e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP1A1—lung cancer	4.03e-06	6.53e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ERCC2—lung cancer	4e-06	6.48e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—lung cancer	3.97e-06	6.43e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP1A1—lung cancer	3.94e-06	6.38e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ERCC2—lung cancer	3.9e-06	6.33e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—AKT1—lung cancer	3.84e-06	6.22e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HRAS—lung cancer	3.8e-06	6.15e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTEN—lung cancer	3.78e-06	6.12e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CA—lung cancer	3.65e-06	5.92e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6—lung cancer	3.63e-06	5.89e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—EP300—lung cancer	3.6e-06	5.83e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKT1—lung cancer	3.5e-06	5.67e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—APOA1—lung cancer	3.46e-06	5.61e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—APOA1—lung cancer	3.38e-06	5.47e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT1—lung cancer	3.35e-06	5.43e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.31e-06	5.37e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CG—lung cancer	3.16e-06	5.12e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CG—lung cancer	3.08e-06	5e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—POMC—lung cancer	3.01e-06	4.87e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKT1—lung cancer	2.98e-06	4.84e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—POMC—lung cancer	2.93e-06	4.76e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CREBBP—lung cancer	2.93e-06	4.75e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CREBBP—lung cancer	2.86e-06	4.63e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CD—lung cancer	2.78e-06	4.5e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALB—lung cancer	2.74e-06	4.44e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CD—lung cancer	2.71e-06	4.39e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALB—lung cancer	2.68e-06	4.34e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CA—lung cancer	2.66e-06	4.32e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CB—lung cancer	2.42e-06	3.92e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—lung cancer	2.4e-06	3.89e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CB—lung cancer	2.36e-06	3.83e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—lung cancer	2.34e-06	3.79e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKT1—lung cancer	2.18e-06	3.53e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTEN—lung cancer	2.09e-06	3.39e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTEN—lung cancer	2.04e-06	3.31e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—EP300—lung cancer	1.99e-06	3.23e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—EP300—lung cancer	1.95e-06	3.15e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CA—lung cancer	1.48e-06	2.39e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CA—lung cancer	1.44e-06	2.33e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKT1—lung cancer	1.21e-06	1.95e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKT1—lung cancer	1.18e-06	1.91e-05	CbGpPWpGaD
